25 of the Best Oncologists Near Me in springfield, VA

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner-Iii is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy. Dr. Tanner-Iii is board certified in American Board Of Obstetrics And Gynecology. Dr. Tanner-Iii is currently accepting new patients.

Ivan Aksentijevich is an Oncologist and a Hematologist practicing medicine in Alexandria, Virginia. Dr. Aksentijevich is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma. Dr. Aksentijevich is currently accepting new patients.

Alexander Spira is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Spira is highly rated in 88 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Spira is currently accepting new patients.

Jacob Ninan is an Oncologist and a Hematologist practicing medicine in Alexandria, Virginia. Dr. Ninan is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Pulmonary Embolism, Saddle Pulmonary Embolism, and Colorectal Cancer. Dr. Ninan is currently accepting new patients.

Alina Huang is an Oncologist and a Hematologist practicing medicine in Alexandria, Virginia. Dr. Huang is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pulmonary Embolism, and Familial Colorectal Cancer. Dr. Huang is currently accepting new patients.

"Dr. Timothy Cannon is Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova. He is a specialty care physician board certified in medical oncology. He has a special interest in management of gastrointestinal malignancies.Dr. Cannon is the clinical director and moderator of the weekly molecular tumor board at Inova, which matches patients with targeted therapies based on molecular diagnostics. He is very interested in national cooperative group clinical trials and is a member of the NRG colorectal and non-colorectal clinical trials committee. He is the site principal investigator for multiple clinical trials in immunotherapy.Dr. Cannon is chair-elect of the steering committee for the TAPUR trial, which is the largest oncology basket trial in North America. He also served as the chief fellow of hematology/oncology at New York University (NYU). Dr. Cannon was voted fellow of the year at NYU during each of his last two years there. He received a ""best doctor"" award by Northern Virginia magazine in 2015.A native of New Jersey, Dr. Cannon is married with two sons. His wife, Amy, works for Save the Children. In his spare time, he likes to play sports (particularly soccer, flag football, tennis) and read books. He was a member of two Division I basketball teams (University of Utah as a freshman and then later at Brigham Young University) in the 1990s and continues to be a huge basketball fan.". Dr. Cannon is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Cannon is currently accepting new patients.

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Sahebjam is board certified in American Board Of Internal Medicine. Dr. Sahebjam is currently accepting new patients.

Gaylord Rose is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Annandale, Virginia. Dr. Rose is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Bladder Reconstruction. Dr. Rose is currently accepting new patients.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon-Ching is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Prostate Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.

Leslie Randall is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Randall is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hysterectomy. Dr. Randall is currently accepting new patients.

Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Subramanian is currently accepting new patients.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Levy is board certified in American Board Of Internal Medicine. Dr. Levy is currently accepting new patients.

Christina Annunziata is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Annunziata is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Testicular Yolk Sac Tumor. Dr. Annunziata is currently accepting new patients.

Dr. Yoomi Lee is a specialty care physician board certified in medical oncology, hematology and internal medicine. She joined Inova Medical Group with more than ten years of clinical experience. She has a special interest in the management of gastrointestinal malignancies. Most recently, Dr. Lee served as a medical oncologist at Maryland Oncology Hematology and prior to that as an attending physician at Columbia University Medical Center. Dr. Lee has had a lifelong interest in science and became interested in oncology during her undergraduate education at Yale University. Her goal is to help her patients access state-of-the-art multidisciplinary cancer care in a supportive environment. A native of Seoul, South Korea, and Sydney, Australia, Dr. Lee currently resides in Washington, DC, with her husband and son. In her spare time, she likes to read books, travel and cook. Dr. Lee is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Myelodysplastic Syndrome (MDS). Dr. Lee is currently accepting new patients.

"Dr. Patricia Rizzo only takes appointments for breast cancer patients. Dr. Patricia C. Rizzo is a medical oncologist board certified in hematology and oncology. She has a special interest in the management of breast cancer. She carries many years of extensive experience in the treatment of malignant hematologic disorders and solid tumors. She enjoys working with patients and their families to provide an atmosphere of care, respect and open communication. Dr. Rizzo believes that it is a privilege to help navigate the journey for patients and their families and that ""every glass is always half full."" There is much more that a physician must provide beyond giving medicine. Dr. Rizzo served as an assistant professor at Georgetown University Lombardi Cancer Center and has been practicing medical oncology in the DC area as a community-based physician for almost two decades. She joined Inova Medical Group with more than twenty-three years of clinical experience. A native of Northern Virginia, Dr. Rizzo currently resides in Mclean, Virginia, with her husband, four children and two dogs.". Dr. Rizzo is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Breast Cancer in Men, and Inflammatory Breast Cancer. Dr. Rizzo is currently accepting new patients.

George Maxwell is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Falls Church, Virginia. Dr. Maxwell is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Uterine Fibroids, Hysterectomy, and Intrauterine Device Insertion. Dr. Maxwell is currently accepting new patients.

David Vesole is an Oncologist and a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Vesole is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine. Dr. Vesole is currently accepting new patients.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Markowski is currently accepting new patients.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine. Dr. Kressel is currently accepting new patients.

Robert Christie is an Oncologist and a Hematologist practicing medicine in Arlington, Virginia. Dr. Christie is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Multiple Myeloma, and Paget Disease of the Breast. Dr. Christie is currently accepting new patients.

Dr. Nicole Laslett is a specialty care physician board certified in internal medicine, medical oncology, and hematology. She joined Inova in 2025 and has been practicing since 2015. Prior to joining Inova, Dr. Laslett served as a physician at Christiana Care Oncology Hematology at the Helen F. Graham Cancer Center and Research Institute in Newark, DE, where she was also a Core Faculty member. Additionally, she held academic appointments as a Clinical Assistant Professor of Medicine at both Thomas Jefferson University and the Philadelphia College of Osteopathic Medicine. Dr. Laslett is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and HER-2 Positive Breast Cancer. Dr. Laslett is currently accepting new patients.

Neelima Denduluri is an Oncologist practicing medicine in Arlington, Virginia. Dr. Denduluri is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, HER2 Negative Breast Cancer, and Salpingo-Oophorectomy. Dr. Denduluri is currently accepting new patients.

Danielle Shafer is an Oncologist and a Hematologist practicing medicine in Fairfax, Virginia. Dr. Shafer is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Myringotomy. Dr. Shafer is currently accepting new patients.

Mark Goldstein is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Goldstein is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Goldstein is board certified in American Board Of Internal Medicine. Dr. Goldstein is currently accepting new patients.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine. Dr. Pishvaian is currently accepting new patients.